I haven't yet got around to looking at SPL in any detail yet, but their latest prang in not encouraging. It would appear that don't have a very good handle on the FDA approval process and points to weaknesses in their management.
- Forums
- Commodities
- Biotech Analysts $4M pa
Biotech Analysts $4M pa, page-14
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review